However, a study from Mori et al. reported that CD8+ T cells didn’t indicate the anti-tumor immunity in NSCLC [21] and high infiltration of CD8+ T cells didn’t predict better prognosis. The gene discussed is CD8A; the disease is non-small cell lung carcinoma.